You have no items in your shopping cart.
Description
Images & Validation
−
| Application Notes |
|---|
Key Properties
−| Source | CHO Cell |
|---|---|
| Expression System | Eukaryotic cell |
| Biological Origin | Human |
| Endotoxins | ≤10 EU/mg |
| MW | 19.7kDa |
| Purity | ≥95% |
Storage & Handling
−| Storage | Use a manual defrost freezer and avoid repeated freeze - thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -93°C under sterile conditions after reconstitution. |
|---|---|
| Form/Appearance | Lyophilized Powder |
| Expiration Date | 6 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−Similar Products
−Recombinant Human Leukemia inhibitory factor (LIF) (Active) [orb1095883]
Greater than 90% as determined by SDS-PAGE.
48.6 kDa
Mammalian cell
1 mg, 20 μg, 100 μgHuman LIF protein [orb594754]
Greater than 95% as determined by SDS-PAGE.
19.7 kDa
E.coli
1 mg, 500 μg, 10 μg, 50 μgHuman LIF protein (Active) [orb359146]
> 98% as determined by SDS-PAGE and HPLC.
19.7 kDa
E.Coli
5 μg, 100 μg, 500 μgRecombinant human LIF protein (HEK293) [orb1516392]
> 95% as determined by Tris-Bis PAGE; > 95% as determined by SEC-HPLC
Due to glycosylation, the protein migrates to 40-55 kDa based on Tris-Bis PAGE result. kDa
50 μgRecombinant human LIF R protein, C-hFc (HEK293) [orb1516391]
> 95% as determined by Tris-Bis PAGE; > 95% as determined by SEC-HPLC
Due to glycosylation, the protein migrates to 120-140 kDa based on Tris-Bis PAGE result. kDa
50 μg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].








